Video: Two Mega Tailwinds for Indian Biotech — Semaglutide + Rupee ₹94
Two Mega Tailwinds for Indian Biotech: Semaglutide Patent Expiry + Rupee at ₹94/$ — Why This Is a Golden Moment for Quality Biotech Stocks
March 21, 2026Watch: Two Mega Tailwinds for Indian Biotech
Semaglutide patent expiry + Rupee at ₹94 = Golden moment for biotech exporters.
Disclaimer: Educational only. Manish Goel, SEBI Reg. Advisor (INA100007736)